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OBJECTIVES: Although carbon monoxide poisoning is a major medical emergency, the armamentarium of
recognized prognostic biomarkers displays unsatisfactory diagnostic performance for predicting cumulative
endpoints.
METHODS: We performed a retrospective and observational study to identify all patients admitted for carbon
monoxide poisoning during a 2-year period. Complete demographical and clinical information, along with the
laboratory data regarding arterial carboxyhemoglobin, hemoglobin, blood lactate and total serum bilirubin,
was retrieved.
RESULTS: The study population consisted of 38 poisoned patients (23 females and 15 males; mean age 39±21
years). Compared with discharged subjects, hospitalized patients displayed significantly higher values for blood
lactate and total serum bilirubin, whereas arterial carboxyhemoglobin and hemoglobin did not differ. In a
univariate analysis, hospitalization was significantly associated with blood lactate and total serum bilirubin, but
not with age, sex, hemoglobin or carboxyhemoglobin. The diagnostic performance obtained after combining
the blood lactate and total serum bilirubin results (area under the curve, 0.90; 95% CI, 0.81-0.99; po0.001) was
better than that obtained for either parameter alone.
CONCLUSION: Although it remains unclear whether total serum bilirubin acts as an active player or a bystander,
we conclude that the systematic assessment of bilirubin may, alongside lactate levels, provide useful
information for clinical decision making regarding carbon monoxide poisoning.
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’ INTRODUCTION
Although carbon monoxide (CO) poisoning is a major
medical emergency, resulting in more than 50,000 emergency
department (ED) visits each year in the United States (1), the
pathophysiology of this condition is still incompletely under-
stood. It is widely assumed that CO can cause hypoxia by
directly binding to hemoglobin molecules with an affinity up
to 200 times greater than that of oxygen for hemoglobin, thus
leading to the generation of carboxyhemoglobin (COHb) and
a left shift in oxyhemoglobin dissociation, which ultimately
decrease oxygen delivery to peripheral tissues (1). Never-
theless, other, more complex mechanisms have been recently
postulated, such as the generation of enhanced oxidative
stress due to a direct increase in cytosolic heme levels (2) or
the direct binding of CO to tissue heme proteins and
cytochrome C oxidase (3), which severely compromises
cellular respiration and increases the endogenous generation
of reactive oxygen species (ROS) (4). This pernicious
biochemical cascade not only leads to cell injury, inflammation
and metabolic acidosis (1) but also triggers a defensive
response from the organism, which is mainly mediated by
the activation of several antioxidant and anti-inflammatory
mechanisms (5,6).
Notably, CO can also be generated by physiological
mechanisms during toxic exposure, and more specifically
by heme metabolism, as initially demonstrated by Sjöstrand
more than sixty years ago (7,8). A class of enzymes, namely,DOI: 10.6061/clinics/2015(09)06
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the heme oxygenases (HOs), share the function of metaboliz-
ing the heme molecule. This process is associated with the
generation of equimolar amounts of CO and biliverdin, the
latter of which is then promptly converted into bilirubin by a
specific reductase (9). Interestingly, HO is present in two
genetically distinct isoforms, or HO-1 and HO-2. The latter
isoenzyme is constitutively expressed, whereas the former
HO-1 isoenzyme belongs to the family of heat-shock
proteins, and its synthesis can be induced by a wide
spectrum of chemical and physical stressor agents, including
hypoxia and CO (10,11). Bilirubin, one of the products gene-
rated by heme metabolism, is currently regarded as a natural
antioxidant and a potent scavenger of ROS (12,13). Recent
evidence also suggests that serum bilirubin levels inversely
correlate with cardiovascular diseases and mortality (14,15).
Because COHb levels are poor predictors of hospitaliza-
tion and outcome in CO-poisoned patients (16,17), increased
focus is currently being placed on the identification of
additional indices of the severity and outcome of CO
exposure. In particular, a limited amount of evidence of the
predictive value of cardio-specific troponins (18), lactate
(19,20), copeptin (21) and protein S-100B (22) in CO-poisoned
patients is accumulating.
Due to the intriguing relationship that exists between
bilirubin and CO metabolism, the goal of this study was to
assess whether total serum bilirubin levels, which are
considered as the expression of the anti-inflammatory
response of the organism to poisoning, has a role in
predicting the short-term outcome (i.e., the need for
hospitalization) of CO-poisoned patients.
’ MATERIALS AND METHODS
In this retrospective and observational study, all patients
referred to the ED of the Academic Hospital of Parma due to
CO poisoning from 2012-2013 were identified in the hospital
database. According to local practice, arterial COHb,
hemoglobin and blood lactate are routinely measured in all
patients with suspected CO poisoning in the ED itself using
the blood gas analyzer Radiometer ABL800 FLEX (Radio-
meter Medical ApS, Bronshoj, Denmark), whereas total
serum bilirubin is assessed in the central laboratory using a
Beckman Coulter AU5800 instrument and the azobilirubin
assay (Beckman Coulter Inc., Brea, CA, USA). For the
purposes of this investigation, CO poisoning was diagnosed
only in the presence of an arterial COHb concentration
greater than 2% in non-smokers and greater than 9% in
smokers, in association with a history suggestive of recent
CO exposure along with clinical features of CO poisoning. At
our institution, the hospitalization of a CO-poisoned subject
is determined by the emergency physician in charge of the
patient, according to clinical judgment. All cases were of
domestic origin, i.e., due to problems with the heating
system in the patient’s house.
The normality of the distribution of values was verified
using the Shapiro-Wilk test. The data were found to be non-
normally distributed and were thus ultimately reported as
the median and interquartile range (IQR). The significance
of differences between discharged and hospitalized
patients was assessed with the Wilcoxon-Mann-Whitney test.
Univariate analysis (Spearman’s correlation) was then
performed to define potential associations between clinical
outcome data and demographical or laboratory data. The
statistical analysis was performed using Analyse-it (Analyse-
it Software Ltd, Leeds, UK). The study was performed in
accordance with the Declaration of Helsinki and under the
terms of relevant local legislation.
’ RESULTS
Complete information could be found for 38 CO-poisoned
patients (23 females and 15 males; mean age 39±21 years)
from the retrospective analysis of 2012-2013 admissions.
Among these patients, 10 (26%) were hospitalized for
insufficient recovery after acute treatment and/or clinical
signs of organ dysfunction (principally for heart injury and/
or cardiac dysfunction). No deaths occurred in the 2 weeks
following initial admission to the ED. The main findings of
this study are summarized in table 1. Compared with the
discharged subjects, the patients in the hospitalized group
were older and displayed significantly higher values for both
blood lactate and total serum bilirubin, whereas the
hemoglobin and arterial COHb values did not differ
significantly between the groups. The range of total serum
bilirubin values in the whole population of CO-poisoned
patients (i.e., 3.4-21 mmol/L) largely overlapped with the
normal reference range of the local laboratory (3-20 mmol/L).
In the univariate analysis, hospitalization was found to be
significantly associated with blood lactate and total serum
bilirubin, but not with age, sex, hemoglobin or COHb.
Additionally, strong positive correlations were found between
blood lactate and CO (r=0.417; p=0.009) and between
hemoglobin and total serum bilirubin (r=0.430, p=0.026).
The area under the curve (AUC) for predicting hospitali-
zation was 0.85 (95% CI, 0.72-0.97; po0.001) for blood lactate
and 0.79 (95% CI, 0.65-0.93; po0.001) for serum bilirubin. At
a threshold of 41.20 mmol/L blood lactate, the sensitivity
and specificity for predicting hospitalization were 1.00
(95% CI, 0.69-1.00) and 0.57 (95% CI, 0.37-0.76), respectively.
At a threshold of total serum bilirubin 46.8 mmol/L, the
Table 1 - Values (median and interquartile range) for 38 patients with acute carbon monoxide poisoning, stratified
according to hospital admission, and univariate analysis (Spearman’s correlation) for the prediction of hospitalization
in carbon monoxide-poisoned patients.
No. hospitalizations (28) Hospitalizations (10) p-value Spearman’s correlation
Age (years) 35 (25-45) 45 (37-25) 0.035 r=0.297; p=0.070
Gender (Females/Males) 18/10 5/5 0.342 r=0.123; p=0.441
Hemoglobin (g/L) 135 (123-145) 124 (120-134) 0.274 r=-0.120; p=0.548
Carboxyhemoglobin (%) 15.0 (8.1-21.4) 18.8 (12.4-30.0) 0.091 r=0.221; p=0.181
Blood lactate (mmol/L) 1.0 (1.1-1.5) 1.8 (1.4-2.0) o0.001 r=0.534; po0.001
Total serum bilirubin (mmol/L) 6.8 (5.1-9.3) 10.3 (9.0-13.0) 0.005 r=0.417; p=0.009
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sensitivity and specificity for predicting hospitalization
were 1.00 (95% CI, 0.69-1.00) and 0.54 (95% CI, 0.34-0.72),
respectively. Interestingly, the diagnostic performance
obtained after combining the blood lactate and total serum
bilirubin results (AUC, 0.90; 95% CI, 0.81-0.99; po0.001) was
better than that obtained for either parameter alone
(Figure 1). The sensitivity and specificity of this combination
(both parameters with cut-off values obtained from receiver
operating characteristic (ROC) curves) were 1.00 (95% CI,
0.69-1.00) and 0.79 (95% CI, 0.59-0.92), respectively.
’ DISCUSSION
The results of this study are the first to show that the total
serum bilirubin level at patient admission in the ED is a
significant predictor of hospitalization among CO-poisoned
patients and that its combination with the blood lactate value
predicts hospital admission with high accuracy (AUC, 0.89).
It is also noteworthy that the total serum bilirubin
concentration per se did not influence the decision regarding
hospital admission or discharge because the values were
virtually identical to those of the normal reference range.
There is an intriguing and mutual relationship between
CO, lactate and bilirubin, which may provide a reasonable
explanation for these findings. As previously reported, HO is
a key enzyme in bilirubin metabolism because it catalyzes
the conversion of heme into bilirubin. More specifically, HO
participates in the rate-limiting first step of the oxidative
degradation of Fe-protoporphyrin-IX into biliverdin, which
is subsequently converted into bilirubin by an NAD(P)H-
dependent reductase. The process of biliverdin generation,
which requires three molecules of molecular oxygen (O2) and
one molecule of NADPH, generates one molecule of ferrous
iron (i.e., Fe2+) along with one molecule of CO (9). Recent
evidence suggests that HO-1 may confer protection against
oxidative stress by enhancing the generation of biliverdin,
bilirubin and iron, given that biliverdin and bilirubin are
powerful endogenous antioxidant compounds (14,15). In
contrast, the iron liberated from heme by HO stimulates the
production of ferritin, which is a well-known cytoprotective
molecule (9).
Considering this evidence along with the results of our
study, it is conceivable that a greater degree of tissue hypoxia
in CO-intoxicated patients, as reflected by higher blood
lactate values, may effectively stimulate the synthesis of
HO-1, which would subsequently enhance the in vivo
generation of CO and bilirubin. This hypothesis is partially
confirmed by the strong positive correlation between blood
lactate and CO observed in this study. A similar pathway
could be suggested for CO because a higher concentration of
COHb may also effectively induce overexpression of HO-1,
thereby enhancing bilirubin synthesis. From this perspective,
increased levels of total serum bilirubin should be considered
as a bystander, rather than as an effective player. Conversely,
it is expected that the higher the conversion of heme to
biliverdin (and then to bilirubin) is, the greater the generation
of endogenous CO will be. Thus, in patients with a high basal
hemoglobin value, increased generation of bilirubin may
occur under stress conditions, such as CO-related hypoxia.
This concept mirrored by the significant correlation between
hemoglobin and total serum bilirubin observed in our
patients. This intriguing relationship may ultimately be
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Figure 1 - Diagnostic performance (receiver operating characteristic curve) of the admission values of total serum bilirubin, blood
lactate and their combination for predicting hospitalization in carbon monoxide-poisoned patients.
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effective in augmenting and maintaining an increased level of
endogenous CO, for which bilirubin levels may also be
considered as an active player, rather than as a simple
bystander. This scenario is consistent with evidence that CO
exerts its effects as both a signaling molecule (13) and a highly
hypoxic agent (23).
COHb levels are poor predictors of hospitalization and
outcome in CO-poisoned patients (16,17), and increased
emphasis is currently being placed on the identification of
additional indices of the severity and outcome of CO
exposure. Among the most useful biomarkers, evidence of
the predictive value of cardio-specific troponins (18), lactate
(19,20), copeptin (21) and protein S-100B (22) in CO-poisoned
patients is accumulating. Among these biomarkers, as
previously reported, blood lactate seems to be the only
significant predictor of hospital admission (20). Nevertheless,
these biomarkers only reflect organ-specific derangements
(i.e., brain or heart injury); hence, they display an overall
unsatisfactory diagnostic performance in terms of predicting
cumulative endpoints such as hospitalization or death (1).
Although it remains unclear whether total serum bilirubin
acts as an active player or a simple bystander, it seems
reasonable to conclude that the systematic assessment of this
simple and inexpensive parameter may provide, alongside
lactate levels, useful information for clinical decision making
regarding CO poisoning.
’ ACKNOWLEDGMENTS
The authors acknowledge Drs. Marco Brambilla and Marco Mignani of the
Academic Hospital of Parma for their kind support in extracting data from
the electronic database of the institution and Nurse Rosa Netti for her kind
support in extracting data from the blood gas analyzer.
’ AUTHOR CONTRIBUTIONS
Cervellin G planned the study and wrote the article. Comelli I, Bonocore R
and Picanza A conducted the data extraction and analysis. Rastelli G and
Lippi G checked the results and reviewed and corrected the manuscript.
’ REFERENCES
1. Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med.
2009;360(12):1217-25, http://dx.doi.org/10.1056/NEJMcp0808891.
2. Cronje FJ, Carraway MS, Freiberger JJ, Suliman HB, Piantadosi CA,
Carbon monoxide actuates O(2)-limited heme degradation in the rat
brain. Free Radic Biol Med. 2004;37(11):1802-12, http://dx.doi.org/
10.1016/j.freeradbiomed.2004.08.022.
3. Alonso JR, Cardellach F, López S, Casademont J, Miró O. Carbon mon-
oxide specifically inhibits cytochrome c oxidase of human mitochondrial
respiratory chain. Pharmacol Toxicol. 2003;93(3):142-26, http://dx.doi.
org/10.1034/j.1600-0773.2003.930306.x.
4. Piantadosi CA. Toxicity of carbon monoxide: hemoglobin vs. histotoxic
mechanisms. In: Penney DG, ed. Carbon monoxide. Boca Raton, FL: CRC
Press, pp. 163-86, 1996.
5. Mannaioni PF, Vannacci A, Masini E. Carbon monoxide: the bad and the
good side of the coin, from neuronal death to anti-inflammatory activity.
Inflamm Res.2006;55(7):261-73, http://dx.doi.org/10.1007/s00011-006-0084-y.
6. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, et al.
Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results
in cytoprotective preconditioning. Proc Natl Acad Sci U S A. 2007;
104(12):5109-14, http://dx.doi.org/10.1073/pnas.0609611104.
7. Sjöstrand T. Endogenous production of carbon monoxide in man under
normal and pathophysiological conditions. Scandinavian Journal of Clin-
ical and Laboratory Investigation 1949;1(1):201-14, http://dx.doi.org/
10.3109/00365514909069943.
8. Sjöstrand T, The formation of carbon monoxide by the decomposition of
hemoglobin in vivo. Acta Physiol Scand. 1952;26(4):338-44, http://dx.doi.
org/10.1111/apha.1952.26.issue-4.
9. Ryter SW, Alam J, Choi AMK. Heme oxygenase-1/carbon monoxide:
From basic science to therapeutic applications. Physioll Rev. 2006;
86(2):583-650, http://dx.doi.org/10.1152/physrev.00011.2005.
10. Chung HT, Ryter SW, Kim HP. Heme oxygenase-1 as a novel metabolic
player. Oxid Med Cell Longev. 2013;2013:814058, http://dx.doi.org/
10.1155/2013/814058.
11. Yang YC, Huang YT, Hsieh CW, Yang PM, Wung BS. Carbon Monoxide
Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial
Cells via S-Glutathionylation. PLoS One. 2014;9(7):e100677, http://dx.doi.org/
10.1371/journal.pone.0100677.
12. Stocker R, Ames BN. Potential role of conjugated bilirubin and copper in
the metabolism of lipid peroxides in bile. Proc Natl Acad Sci U S A.
1987;84(22):8130-4, http://dx.doi.org/10.1073/pnas.84.22.8130.
13. Breimer LH, Mikhailidis DP. Could carbon monoxide and bilirubin be
friends as well as foes of the body? Scand J Clin Lab Invest. 2010;70 (1):1-5.
14. Breimer LH, Spyropolous KA, Winder AF, Mikhailidis DP, Hamilton G. Is
bilirubin protective against coronary artery disease? Clin Chem. 1994;
40(10):1987-8.
15. Franchini M, Targher G, Lippi G. Serum bilirubin levels and cardiovas-
cular disease risk: a Janus Bifrons? Adv Clin Chem. 2010;50:47-63, http://
dx.doi.org/10.1016/S0065-2423(10)50003-9.
16. Hampson NB, Hauff NM. Carboxyhemoglobin levels in carbon monoxide
poisoning: do they correlate with the clinical picture? Am J Emerg Med.
2014 Jun;32(6):665-9, http://dx.doi.org/10.1016/j.ajem.2014.03.001.
17. Hampson NB, Piantadosi CA, Thom SR, Weaver LK. Practice Recom-
mendations in the Diagnosis, Management, and Prevention of Carbon
Monoxide Poisoning Am J Respir Crit Care Med. 2012;186 (11):1095-101.
18. Lippi G, Rastelli G, Meschi T, Borghi L, Cervellin G. Pathophysiology,
clinics, diagnosis and treatment of heart involvement in carbon monoxide
poisoning. Clin Biochem. 2012;45(16-17):1278-85, http://dx.doi.org/
10.1016/j.clinbiochem.2012.06.004.
19. Moon JM, Shin MH, Chun BJ. The value of initial lactate in patients with
carbon monoxide intoxication: in the emergency department. Hum Exp
Toxicol. 2011;30(8):836-43, http://dx.doi.org/10.1177/0960327110384527.
20. Cervellin G, Comelli I, Rastelli G, Picanza A, Lippi G. Initial blood lactate
correlates with carboxyhemoglobin and clinical severity in carbon
monoxide poisoned patients. Clin Biochem. 2014;47(18):298-301, http://
dx.doi.org/10.1016/j.clinbiochem.2014.09.016.
21. Pang L, Wang HL, Wang ZH, Wu Y, Dong N, Xu DH, et al. Plasma
copeptin as a predictor of intoxication severity and delayed neurological
sequelae in acute carbon monoxide poisoning. Peptides. 2014;59:89-93,
http://dx.doi.org/10.1016/j.peptides.2014.07.007.
22. Cakir Z, Aslan S, Umudum Z, Acemoglu H, Akoz A, Turkyilmaz S, et al.
S-100b and neuron-specific enolase levels in carbon monoxide–related
brain injury. Am J Emerg Med. 2010;28(1):61-7, http://dx.doi.org/
10.1016/j.ajem.2008.10.032.
23. Guzman JA. Carbon monoxide poisoning. Crit Care Clin. 2012;28 (4):537-48.
631
CLINICS 2015;70(9):628-631 Serum bilirubin predicts severity of CO poisoning
Cervellin G et al.
